Table E.2.
Chemical name [FL‐no] | Species/sex No/group | Route | Dose levels (mg/kg per day) | Duration | NOAEL (mg/kg per day) | Reference | Comments |
---|---|---|---|---|---|---|---|
(Acetone [07.050]) |
Rat/M,F 10 |
Drinking water | 0, 250, 500, 1,000, 2,000, 5,000 | 13 weeks | 1,000a | Diet (1991) |
NTP study |
Mouse/M,F 10 |
Drinking water |
0, 312, 625, 1,250, 2,500, 5,000 (M) 0, 625, 1,250, 2,500, 5,000, 12,500 (F) |
13 weeks | 2,500a | Dietz (1991) |
NTP study |
|
Rat/M,F 30 |
Gavage | 0, 100, 500, 2,500 | 90 days | 100 | Sonawane et al. (1986) |
Meeting abstract |
|
Rat/NR 3 |
Drinking water | 1,000 | 4 weeks | 1,000a , b | Spencer et al. (1978) |
Examinations were limited to specific neurotoxic effects. No other parameter was monitored |
|
(Isopropyl alcohol [02.079]) |
Human/M 8 |
Oral | 0, 2.6, 6.4 | 6 weeks | 6.4b | Wills et al. (1969) |
Paper published in a peer‐reviewed journal |
Rat/M 22 |
Drinking water | 0, 870, 1,280, 1,680, 2,520 | 12 weeks | 870 | Pilegaard and Ladefoged (1993) |
Good quality study |
|
Pentan‐3‐one [07.084] |
Rat/F 5 |
Drinking water | 0, 1,860 | 120 days | Not detected (< 1,860) | Union Carbide Corp. (1977) | Good quality unpublished report. Focused on neurotoxic effect |
(2‐Heptanone [07.002]) |
Rat/M,F 15 |
Gavage (dissolved in corn oil) | 0, 20, 100, 500 | 13 weeks | 20 | Gaunt et al. (1972) |
Good quality study – peer‐reviewed journal |
Rat/NR 5 |
Drinking Water | 0, 500 | 12 weeks | 500a , b | Spencer et al. (1978) |
Good quality study – peer‐reviewed journal |
|
(3‐Heptanone [07.003]) |
Rat/M 2 |
Gavage | 0, 250, 500, 1,000, 2,000, 4,000 | 14 weeks | 1,000 | O'Donoghue et al. (1984) |
Good quality study – peer‐reviewed journal |
Rat/F NR |
Drinking Water | 1,000 | 120 days | 1,000a | Homan and Maronpot (1978) |
Meeting abstract |
|
Rat/F 5 |
Drinking water | 0, 27 | 120 days | 27b | Union Carbide Corp. (1977) | Good quality unpublished report. Focused on neurotoxic effect | |
(4‐Heptanone [07.058]) |
Rat/M 8 |
Gavage | 0, 1,000 | 90 days |
Not detected (< 1,000) |
O'Donoghue and Krasavage (1980) |
Good quality unpublished report |
Rat/M 3 |
Gavage (undiluted) | 0, 1,000, 2,000, 4,000 | 3 weeks |
Not detected (< 1,000) |
Krasavage and O'Donoghue (1979) |
Good quality unpublished report |
|
(2‐Nonanone [07.020]) |
Rat/M 3 |
Gavage (undiluted) | 0, 1,000, 2,000, 4,000 | 3 weeks |
Not detected (< 1,000) |
Krasavage and O'Donoghue (1979) |
Good quality unpublished report |
Rat/M 8 |
Gavage | 0, 2,000 | 90 days |
Not detected (< 2,000) |
O'Donoghue and Krasavage (1980) |
Good quality unpublished report |
|
(4‐Methyl‐2‐pentanone [07.017]) |
Rat/M,F 5 |
Drinking water | 0, 1,040 | 120 days |
Not detected (< 1,040) |
Union Carbide Corp. (1977) | Good quality unpublished report. Focused on neurotoxic effect |
Rat/F NR |
Drinking water | 1,000 | 120 days | 1,000b | Homan and Maronpot (1978) |
Meeting abstract |
|
Methyl‐5‐heptan‐3‐one [07.182] |
Rat/M 5 |
Gavage (in distilled water) | 82, 410, 820 |
13 weeks (5 days/week) |
82 | IBM Corp. (1989) | Good quality unpublished report submitted to EPA |
(2,6‐Dimethyl‐4‐heptanone [07.122]) |
Rat/M 8 |
Gavage | 0, 2,000 | 90 days |
Not detected (< 2,000) |
O'Donoghue and Krasavage (1980) |
Good quality unpublished report |
(5‐Methyl‐5‐hexen‐2‐one [07.100]) |
Rat/M,F 5 |
Diet | 0, 10 | 14 days | 10b | Gill and Van Miller (1987) |
GLP study – unpublished report |
(2,6,10‐Trimethyl‐2,6,10‐pentadecatrien‐14‐one [07.114]) |
Rat/M,F 5 |
Oral (gavage in maize oil) | 0, 0.35, 3.5 | 14 days | 3.5 | deGroot et al. (1974) |
TNO Unpublished Report |
9‐Decen‐2‐one [07.262] |
Rat/M,F 5 |
Oral (gavage in corn oil) | 0, 250, 500, 1,000 | 28 days | 1,000e | Flavour Industry (2009) | Good study, OECD 407 |
FL‐no: FLAVIS number; NOAEL: no observed adverse effect level.
NR = sex not reported; M = Male; F = Female.
Concentrations converted to mg/kg bw per day using conversion table for test chemical treatment doses used in PAFA (FDA, 1993).
This study was performed at a single dose level that produced no adverse effects.
Summarised by JECFA, 51st meeting (JECFA, 1999a).
Summarised by JECFA 59th meeting (JECFA, 2003).
The highest dose tested.